These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6339296)
1. Protein modification by non-enzymatic glucosylation: possible role in the development of diabetic complications. Wieland OH Mol Cell Endocrinol; 1983 Feb; 29(2):125-31. PubMed ID: 6339296 [No Abstract] [Full Text] [Related]
2. [Role of non-enzymatic glycosylation of proteins in the pathogenesis of diabetic complications]. Sampietro T Minerva Endocrinol; 1988; 13(4):249-51. PubMed ID: 2976478 [No Abstract] [Full Text] [Related]
3. [Non-enzymatic protein glycosylation and its clinico-biological significance]. Tomaszewski L Pol Tyg Lek; 1989 Jan; 44(4):75-80. PubMed ID: 2798209 [No Abstract] [Full Text] [Related]
4. [Disproteinemia in diabetes mellitus and its role in the pathogenesis of diabetic angiopathies]. Efimov AS; Bodnar PN; Limanskaia GF; Lapko LI; Kopytov IuP Probl Endokrinol (Mosk); 1970; 16(6):7-11. PubMed ID: 4255798 [No Abstract] [Full Text] [Related]
9. Glucosylation of human collagen in aging and diabetes mellitus. Schnider SL; Kohn RR J Clin Invest; 1980 Nov; 66(5):1179-81. PubMed ID: 7430347 [TBL] [Abstract][Full Text] [Related]
10. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Steinbrecher UP; Witztum JL Diabetes; 1984 Feb; 33(2):130-4. PubMed ID: 6420216 [TBL] [Abstract][Full Text] [Related]
12. Nonenzymatic glucosylation of serum proteins in diabetes mellitus. McFarland KF; Catalano EW; Day JF; Thorpe SR; Baynes JW Diabetes; 1979 Nov; 28(11):1011-4. PubMed ID: 488539 [TBL] [Abstract][Full Text] [Related]
13. Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts. Cohen MP Biochim Biophys Acta; 2013 Dec; 1830(12):5480-5. PubMed ID: 23624335 [TBL] [Abstract][Full Text] [Related]
14. Site specific modification of the human plasma proteome by methylglyoxal. Kimzey MJ; Kinsky OR; Yassine HN; Tsaprailis G; Stump CS; Monks TJ; Lau SS Toxicol Appl Pharmacol; 2015 Dec; 289(2):155-62. PubMed ID: 26435215 [TBL] [Abstract][Full Text] [Related]
15. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics]. Calvo C Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289 [TBL] [Abstract][Full Text] [Related]
16. [Glycosylated lipoproteins as atherogenic factor in diabetes (review of the literature)]. Denisenko TV Vopr Med Khim; 1990; 36(2):5-10. PubMed ID: 2194367 [TBL] [Abstract][Full Text] [Related]
17. Increased microvascular permeability to plasma proteins in short- and long-term juvenile diabetics. Parving HH Diabetes; 1976; 25(2 SUPPL):884-9. PubMed ID: 9323 [TBL] [Abstract][Full Text] [Related]
19. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Guthrow CE; Morris MA; Day JF; Thorpe SR; Baynes JW Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4258-61. PubMed ID: 291961 [TBL] [Abstract][Full Text] [Related]
20. Elucidating the impact of glucosylation on human serum albumin: A multi-technique approach. Neelofar KM; Ahmad J; Arif Z; Alam K Int J Biol Macromol; 2016 Nov; 92():881-891. PubMed ID: 27492562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]